Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


2 Alzheimer Dis Assoc Disord
1 Brain
1 Curr Opin Neurol
5 J Alzheimers Dis
2 J Neural Transm (Vienna)
1 J Neurochem
1 J Neurol
1 J Neuropsychol
1 Nature
1 Nervenarzt
1 Neurobiol Aging
1 Neurochem Res
1 Neurologia (Engl Ed)
3 PLoS One

    Alzheimer Dis Assoc Disord

  1. FU J, Ji X, Liu J, Chen X, et al
    Meta-analysis of the Connection Between Alzheimer Disease and Telomeres.
    Alzheimer Dis Assoc Disord. 2021 Oct 15. pii: 00002093-900000000-99214.
    >> Share

  2. KIM HR, Lee T, Choi JK, Jeong Y, et al
    Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid beta on Neurodegeneration.
    Alzheimer Dis Assoc Disord. 2021;35:114-120.
    >> Share


  3. VINOGRADOVA Y, Dening T, Hippisley-Cox J, Taylor L, et al
    Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
    BMJ. 2021;374:n2182.
    >> Share


  4. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    >> Share

    Curr Opin Neurol

  5. KAWAS CH, Legdeur N, Corrada MM
    What have we learned from cognition in the oldest-old.
    Curr Opin Neurol. 2021;34:258-265.
    >> Share

    J Alzheimers Dis

  6. KURKINEN M, Tran L
    Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215105. doi: 10.3233/JAD-215105.
    >> Share

  7. ARANDELOVIC J, Santrac A, Batinic B, Todorovic L, et al
    Positive and Negative Selective Allosteric Modulators of alpha5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215079. doi: 10.3233/JAD-215079.
    >> Share

  8. LIU H, Lutz M, Luo S
    Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD210700. doi: 10.3233/JAD-210700.
    >> Share

  9. HOFMANN C, Sander A, Wang XX, Buerge M, et al
    Inhalational Anesthetics Do Not Deteriorate Amyloid-beta-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD201185. doi: 10.3233/JAD-201185.
    >> Share

  10. HU D, Liu C, Xia K, Abramowitz A, et al
    Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD215160. doi: 10.3233/JAD-215160.
    >> Share

    J Neural Transm (Vienna)

  11. HANSEN N, Malchow B, Zerr I, Stocker W, et al
    Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort.
    J Neural Transm (Vienna). 2021;128:357-369.
    >> Share

  12. WINKEL I, Ermann N, Zelwetro A, Sambor B, et al
    Cerebrospinal fluid alpha synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms.
    J Neural Transm (Vienna). 2021;128:817-825.
    >> Share

    J Neurochem

    Preface: Mass spectrometry in Alzheimer disease: This is the Preface for the special issue "Mass Spectrometry in Alzheimer Disease".
    J Neurochem. 2021;159:207-210.
    >> Share

    J Neurol

  14. CONTADOR J, Perez-Millan A, Guillen N, Tort-Merino A, et al
    Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease.
    J Neurol. 2021 Oct 19. pii: 10.1007/s00415-021-10851.
    >> Share

    J Neuropsychol

  15. STRIJKERT F, Huitema RB, Spikman JM
    Measuring emotion recognition: Added value in diagnosing dementia of the Alzheimer's disease type.
    J Neuropsychol. 2021 Oct 18. doi: 10.1111/jnp.12263.
    >> Share


  16. STAHLBERG H, Riek R
    Structural strains of misfolded tau protein define different diseases.
    Nature. 2021;598:264-265.
    >> Share


  17. HAUSSMANN R, Homeyer P, Donix M, Linn J, et al
    [Current findings on the coincidence of cerebral amyloid angiopathy and Alzheimer's disease].
    Nervenarzt. 2021 Oct 15. pii: 10.1007/s00115-021-01213.
    >> Share

    Neurobiol Aging

  18. KOENIG LN, LaMontagne P, Glasser MF, Bateman R, et al
    Regional age-related atrophy after screening for preclinical alzheimer disease.
    Neurobiol Aging. 2021;109:43-51.
    >> Share

    Neurochem Res

  19. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    >> Share

    Neurologia (Engl Ed)

  20. IZQUIERDO DELGADO E, Gutierrez Rios R, Andres Calvo M, Repiso Gento I, et al
    Nutritional status assessment in Alzheimer disease and its influence on disease progression.
    Neurologia (Engl Ed). 2021 Oct 14. pii: S2173-5808(21)00167.
    >> Share

    PLoS One

  21. FERNANDEZ-BLAZQUEZ MA, Del Ser T, Frades-Payo B, Avila-Villanueva M, et al
    MADRID+90 study on factors associated with longevity: Study design and preliminary data.
    PLoS One. 2021;16:e0251796.
    >> Share

  22. CALDERON C, Beyle C, Veliz-Garcia O, Bekios-Calfa J, et al
    Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
    PLoS One. 2021;16:e0251137.
    >> Share

  23. AKBOR MM, Kurosawa N, Nakayama H, Nakatani A, et al
    Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.
    PLoS One. 2021;16:e0248027.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016